These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1276 related items for PubMed ID: 18579534

  • 1. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [Abstract] [Full Text] [Related]

  • 2. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
    Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.
    Nephron Clin Pract; 2008 Nov; 110(1):c58-65. PubMed ID: 18724068
    [Abstract] [Full Text] [Related]

  • 3. Vitamin D deficiency and associated factors in hemodialysis patients.
    Jean G, Charra B, Chazot C.
    J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
    [Abstract] [Full Text] [Related]

  • 4. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation.
    Jean G, Souberbielle JC, Chazot C.
    Nephrol Dial Transplant; 2009 Dec; 24(12):3799-805. PubMed ID: 19622574
    [Abstract] [Full Text] [Related]

  • 5. On-line haemodiafiltration improves response to calcifediol treatment.
    Pérez-García R, Albalate M, de Sequera P, Alcázar R, Puerta M, Ortega M, Corchete E.
    Nefrologia; 2012 Jul 17; 32(4):459-66. PubMed ID: 22652556
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
    Blair D, Byham-Gray L, Lewis E, McCaffrey S.
    J Ren Nutr; 2008 Jul 17; 18(4):375-82. PubMed ID: 18558303
    [Abstract] [Full Text] [Related]

  • 7. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Jul 17; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 8. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study.
    Gu Y, Ding F, Chen N, Mei CL, Qian JQ, Wang XY, Shi W, Hou FF, Li XW, Wang M, Chen YP.
    Ren Fail; 2005 Jul 17; 27(2):205-12. PubMed ID: 15807187
    [Abstract] [Full Text] [Related]

  • 9. Effects of reduced dialysate calcium on calcium-phosphorus product and bone metabolism in hemodialysis patients.
    Fiedler R, Deuber HJ, Langer T, Osten B, Mohan S, Jehle PM.
    Nephron Clin Pract; 2004 Jul 17; 96(1):c3-9. PubMed ID: 14752247
    [Abstract] [Full Text] [Related]

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 17; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 11. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients.
    Tokmak F, Quack I, Schieren G, Sellin L, Rattensperger D, Holland-Letz T, Weiner SM, Rump LC.
    Nephrol Dial Transplant; 2008 Dec 17; 23(12):4016-20. PubMed ID: 18593741
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.
    Del Valle E, Negri AL, Aguirre C, Fradinger E, Zanchetta JR.
    Hemodial Int; 2007 Jul 17; 11(3):315-21. PubMed ID: 17576296
    [Abstract] [Full Text] [Related]

  • 13. Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens.
    Minisola S, Cianferotti L, Biondi P, Cipriani C, Fossi C, Franceschelli F, Giusti F, Leoncini G, Pepe J, Bischoff-Ferrari HA, Brandi ML.
    Osteoporos Int; 2017 Nov 17; 28(11):3239-3249. PubMed ID: 28815282
    [Abstract] [Full Text] [Related]

  • 14. Intravenous alfacalcidol once versus twice or thrice weekly in hemodialysis patients.
    Alghareeb A, Sabry A, Bawadekji H, Alsaran K.
    Ther Apher Dial; 2013 Feb 17; 17(1):30-4. PubMed ID: 23379490
    [Abstract] [Full Text] [Related]

  • 15. Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its correction.
    Brazier M, Kamel S, Maamer M, Agbomson F, Elesper I, Garabedian M, Desmet G, Sebert JL.
    J Bone Miner Res; 1995 Nov 17; 10(11):1753-61. PubMed ID: 8592953
    [Abstract] [Full Text] [Related]

  • 16. Risk in dosing regimens for 25-OH vitamin D supplementation in chronic haemodialysis patients.
    Albalate M, de la Piedra C, Ortiz A, Hernández Pérez J, Rubert M, Pérez Garcia R, Zazo P, Nieto L, de Sequera P, Egido J.
    Nephron Clin Pract; 2012 Nov 17; 121(3-4):c112-9. PubMed ID: 23221739
    [Abstract] [Full Text] [Related]

  • 17. Implementation of 'K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease' after the introduction of cinacalcet in a population of patients on chronic haemodialysis.
    Arenas MD, Alvarez-Ude F, Gil MT, Moledous A, Malek T, Nuñez C, Devesa R, Carretón MA, Soriano A.
    Nephrol Dial Transplant; 2007 Jun 17; 22(6):1639-44. PubMed ID: 17277339
    [Abstract] [Full Text] [Related]

  • 18. Low-dose alfacalcidol controls secondary hyperparathyroidism in predialysis chronic kidney disease.
    Reichel H.
    Nephron Clin Pract; 2010 Jun 17; 114(4):c268-76. PubMed ID: 20090369
    [Abstract] [Full Text] [Related]

  • 19. Effect of vitamin D supplementation on vitamin D status and bone turnover markers in young adults.
    Barnes MS, Robson PJ, Bonham MP, Strain JJ, Wallace JM.
    Eur J Clin Nutr; 2006 Jun 17; 60(6):727-33. PubMed ID: 16391584
    [Abstract] [Full Text] [Related]

  • 20. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.
    Matias PJ, Jorge C, Ferreira C, Borges M, Aires I, Amaral T, Gil C, Cortez J, Ferreira A.
    Clin J Am Soc Nephrol; 2010 May 17; 5(5):905-11. PubMed ID: 20203163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.